Antifungal drug resistance: limited data, dramatic impact?

Thomas R Rogers1

  • 1Department of Clinical Microbiology, Trinity College Dublin, St. James's Hospital, Ireland. rogerstr@tcd.ie

Insights

Antifungal drug resistance is a growing concern, particularly with fluconazole use in HIV patients. This review examines antifungal resistance patterns and management strategies for fungal infections.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Pharmacology

Background:

  • Increasing clinical use of antifungal agents raises concerns about emerging drug resistance.
  • Fluconazole resistance is notable in HIV-positive patients, impacting Candida infection epidemiology.
  • Emerging antifungals like voriconazole and caspofungin show varying effects on pathogen shifts and resistance.

Purpose of the Study:

  • To examine current data on antifungal drug resistance.
  • To explore clinical management strategies for fungal infections in light of resistance.
  • To highlight the need for more evidence linking in vitro resistance to clinical outcomes.

Main Methods:

  • Review of existing literature on antifungal drug resistance.
  • Analysis of epidemiological shifts in Candida infections.
  • Discussion of clinical management approaches.

Main Results:

  • Antifungal resistance is a significant clinical challenge, particularly with fluconazole.
  • Lipid formulations of amphotericin B demonstrate uncommon drug resistance.
  • Standardized susceptibility testing for Candida spp. exists, but data linking in vitro resistance to treatment failure are limited.

Conclusions:

  • Further evidence-based data are crucial to confirm the link between in vitro antifungal resistance and clinical treatment failure.
  • Effective clinical management strategies are needed to address the growing threat of antifungal resistance.
  • Monitoring resistance patterns and judicious use of antifungals are essential for patient care.

Related Concept Videos

Antifungal Agents01:15

Antifungal Agents

Amphotericin B is a broad-spectrum antifungal agent that exploits structural differences between fungal and mammalian cell membranes. Its amphipathic structure—featuring a hydrophobic polyene-lactone ring and a hydrophilic region containing mycosamine and carboxylic acid groups—enables selective binding to ergosterol, a sterol predominantly found in fungal plasma membranes. This selective interaction underlies the drug’s antifungal activity, although weak binding to cholesterol contributes to...
Antimicrobial Effectiveness01:28

Antimicrobial Effectiveness

The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions01:15

Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions

PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Candidiasis01:20

Candidiasis

Candidiasis is a fungal infection caused by opportunistic species of Candida. It can affect various anatomical sites, including the skin, oral cavity, nails, and genitourinary tract. Among its forms, vaginal candidiasis is the most common type of mucosal infection. It typically results from the overgrowth of Candida albicans in the vaginal mucosa. Under normal conditions, C. albicans exists as a commensal organism within the vaginal microbiota, regulated by the dominance of lactobacilli, which...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...